Release Date: 23/08/13 09:53 Summary: FY13 Results Announcement Price Sensitive: Yes Download Document 204.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%